COO - The Cooper Companies, Common Stock
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2166484020
Contact Lenses, Fertility Products, Medical Devices, Contraceptives
The Cooper Companies, Inc. is a leading developer, manufacturer, and marketer of innovative healthcare solutions, with a focus on improving the lives of people around the world. Through its two main segments, CooperVision and CooperSurgical, the company offers a diverse range of products and services that cater to the needs of contact lens wearers, healthcare professionals, and patients globally.
CooperVision, the company's contact lens segment, specializes in designing and manufacturing a wide range of spherical lenses, toric lenses, and multifocal lenses that correct various vision challenges, including near and farsightedness, astigmatism, presbyopia, and myopia. With a strong presence in the Americas, Europe, Middle East, Africa, and Asia Pacific, CooperVision is committed to providing high-quality contact lenses that enhance the visual experience of its customers.
CooperSurgical, the company's surgical and fertility segment, focuses on advancing family and women's healthcare through its comprehensive range of products and services. The segment offers a variety of surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices, and uterine positioning products, among others. Additionally, CooperSurgical provides fertility products and services, such as fertility consumables, equipment, donor gamete services, and genomic services, including genetic testing. The segment also offers cryostorage services, including cord blood and cord tissue storage, to healthcare professionals and patients worldwide.
The company's products and services are sold to a diverse customer base, including distributors, group purchasing organizations, eye care and healthcare professionals, independent practices, corporate retailers, hospitals, clinics, and authorized resellers. With a strong commitment to innovation, quality, and customer satisfaction, The Cooper Companies, Inc. has established itself as a trusted partner in the healthcare industry.
Founded in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California, and has a rich history of innovation and growth. Today, the company is a leading player in the global healthcare market, with a strong presence in over 100 countries worldwide. For more information, please visit the company's website at https://www.coopercos.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
COO Stock Overview
Market Cap in USD | 21,473m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Supplies |
TER | 0.00% |
IPO / Inception | 1983-12-30 |
COO Stock Ratings
Growth 5y | 33.4 |
Fundamental | 20.1 |
Dividend | 9.38 |
Rel. Performance vs Sector | 0.83 |
Analysts | 4.11/5 |
Fair Price Momentum | 100.99 USD |
Fair Price DCF | 23.70 USD |
COO Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 65.6% |
COO Growth Ratios
Growth Correlation 3m | 62.7% |
Growth Correlation 12m | 52.5% |
Growth Correlation 5y | 29.6% |
CAGR 5y | 7.73% |
CAGR/Mean DD 5y | 0.51 |
Sharpe Ratio 12m | 1.15 |
Alpha vs SP500 12m | -5.93 |
Beta vs SP500 5y weekly | 1.02 |
ValueRay RSI | 28.06 |
Volatility GJR Garch 1y | 20.12% |
Price / SMA 50 | -0.21% |
Price / SMA 200 | 8.74% |
Current Volume | 950.9k |
Average Volume 20d | 1215k |
External Links for COO Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 29, 2024, the stock is trading at USD 105.51 with a total of 950,918 shares traded.
Over the past week, the price has changed by -1.13%, over one month by -3.89%, over three months by +13.93% and over the past year by +35.38%.
According to ValueRays Forecast Model, COO The Cooper Companies, Common Stock will be worth about 111.4 in October 2025. The stock is currently trading at 105.51. This means that the stock has a potential upside of +5.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 113.9 | 7.99 |
Analysts Target Price | 400.2 | 279 |
ValueRay Target Price | 111.4 | 5.55 |